Patents by Inventor Gennady Smagin

Gennady Smagin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MOVEMENT DISORDERS
    Publication number: 20230301985
    Abstract: A method of treating movement disorders, by administering an effective amount of a psychedelic to an individual having a movement disorder, and treating the movement disorder.
    Type: Application
    Filed: May 16, 2023
    Publication date: September 28, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Robert BARROW, Daniel R. KARLIN, Gennady SMAGIN
  • Treatment of Acute Respiratory Distress Syndrome (ARDS)
    Publication number: 20220031700
    Abstract: Methods of preventing, delaying, or reducing the severity of pulmonary extravasation, pulmonary edema, pneumonia, fluid in the lung, acute respiratory distress syndrome, plasma extravasation, and/or pulmonary conditions that develop as a result of hypercytokinemia (cytokine storm syndrome) in a mammal having a medical condition by administering a lyn kinase activator are provided herein.
    Type: Application
    Filed: July 29, 2021
    Publication date: February 3, 2022
    Inventors: Andrew G. Reaume, Gennady Smagin
  • Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
    Publication number: 20120149717
    Abstract: Compounds of general formula: as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain, depression and anxiety.
    Type: Application
    Filed: February 21, 2012
    Publication date: June 14, 2012
    Inventors: William Brown, Andrew Griffin, Thomas Hudzik, Carla Maciag, Gennady Smagin, Christopher Walpole
  • Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
    Patent number: 8129393
    Abstract: Compounds of general formula: as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain, depression and anxiety.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: March 6, 2012
    Assignee: AstraZeneca AB
    Inventors: William Brown, Andrew Griffin, Thomas Hudzik, Carla Maciag, Gennady Smagin, Christopher Walpole
  • Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
    Publication number: 20100168130
    Abstract: Compounds of general formula: as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain, depression and anxiety.
    Type: Application
    Filed: December 22, 2009
    Publication date: July 1, 2010
    Applicant: ASTRAZENECA AB
    Inventors: William Brown, Andrew Griffin, Thomas Hudzik, Carla Maciag, Gennady Smagin, Christopher Walpole
  • Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
    Publication number: 20070249619
    Abstract: Compounds of general formula: as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain, depression and anxiety.
    Type: Application
    Filed: July 27, 2005
    Publication date: October 25, 2007
    Applicant: AstraZeneca AB
    Inventors: William Brown, Andrew Griffin, Thomas Hudzik, Carla Maciag, Gennady Smagin, Christopher Walpole
  • Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
    Publication number: 20060030569
    Abstract: Compounds of general formula: as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain, depression and anxiety.
    Type: Application
    Filed: October 5, 2005
    Publication date: February 9, 2006
    Applicant: AstraZeneca AB
    Inventors: William Brown, Andrew Griffin, Thomas Hudzik, Carla Maciag, Gennady Smagin, Christopher Walpole